Covered recipient · General Payments record
DENISE A MCNATT
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$3,800.79
- Reported across 198 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $831.69 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $277.71 | 10 |
| ABBVIE INC. | $222.54 | 10 |
| GENZYME CORPORATION | $132.37 | 9 |
| UCB, Inc. | $96.93 | 3 |
| Amgen Inc. | $34.50 | 1 |
| Regeneron Healthcare Solutions, Inc. | $25.05 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $16.10 | 1 |
| Verrica Pharmaceuticals Inc. | $13.30 | 1 |
| Galderma Laboratories, L.P. | $13.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.23 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641286 | CMS |
| ABBVIE INC. | $12.29 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641288 | CMS |
| ABBVIE INC. | $24.39 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641290 | CMS |
| ABBVIE INC. | $100.00 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641292 | CMS |
| ABBVIE INC. | $24.18 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641294 | CMS |
| ABBVIE INC. | $1.25 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641296 | CMS |
| ABBVIE INC. | $15.31 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641298 | CMS |
| ABBVIE INC. | $21.57 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641300 | CMS |
| ABBVIE INC. | $8.57 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641302 | CMS |
| ABBVIE INC. | $4.75 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641304 | CMS |
| Amgen Inc. | $34.50 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626710 | CMS |
| Galderma Laboratories, L.P. | $13.19 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145375165 | CMS |
| GENZYME CORPORATION | $10.24 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139656476 | CMS |
| GENZYME CORPORATION | $17.16 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139656484 | CMS |
| GENZYME CORPORATION | $20.14 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139656490 | CMS |
| GENZYME CORPORATION | $26.47 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139656500 | CMS |
| GENZYME CORPORATION | $8.02 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139656510 | CMS |
| GENZYME CORPORATION | $25.34 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139656514 | CMS |
| GENZYME CORPORATION | $5.86 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139656512 | CMS |
| GENZYME CORPORATION | $14.27 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139656518 | CMS |
| GENZYME CORPORATION | $4.87 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139656530 | CMS |
| Lilly USA, LLC | $7.42 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135608089 | CMS |
| Lilly USA, LLC | $18.33 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135608091 | CMS |
| Lilly USA, LLC | $18.05 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135622051 | CMS |
| Lilly USA, LLC | $17.26 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135622053 | CMS |
| Lilly USA, LLC | $27.79 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135608093 | CMS |
| Lilly USA, LLC | $8.58 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135569600 | CMS |
| Lilly USA, LLC | $23.40 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135608727 | CMS |
| Lilly USA, LLC | $19.11 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135569598 | CMS |
| Lilly USA, LLC | $119.60 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135608087 | CMS |
| Lilly USA, LLC | $18.17 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135548903 | CMS |
| Regeneron Healthcare Solutions, Inc. | $25.05 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114341912 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $16.10 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152229507 | CMS |
| UCB, Inc. | $36.44 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143061919 | CMS |
| UCB, Inc. | $31.23 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143061921 | CMS |
| UCB, Inc. | $29.26 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143061923 | CMS |
| Verrica Pharmaceuticals Inc. | $13.30 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118394702 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.